Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical corticosteroid treatment and IL-17 levels in psoriasis
IRCT201606289014N104Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluocinolone and betamethasone in psoriasis, sponsored by Hamadan University of Medical Sciences. Primary endpoint: Change in IL-17 level. Started May 2016; status: completed.
02
Drugs
fluocinolonebetamethasone
03
Conditions
psoriasis
Beyond the preview
Go deeper on IRCT201606289014N104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201606289014N104.